NCT05176548View on ClinicalTrials.gov

Registry of Patients with Suspected Amyloidosis in Heart Failure

Active, not recruitingOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

January 15, 2022

Primary Completion Date

March 31, 2024

Study Completion Date

December 31, 2025

Conditions
Heart Failure
Interventions
DIAGNOSTIC_TEST

Bone-cardiac scintigraphy

Patients with confirmed ATTR type CA will undergo a study of mutations in the TTR gene

Trial Locations (1)

41071

Hospital Universitario Virgen Macarena, Seville

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

OTHER

NCT05176548 - Registry of Patients with Suspected Amyloidosis in Heart Failure | Biotech Hunter | Biotech Hunter